Protagonist Therapeutics reported a net margin of 76.27% for the quarter ended Jun 2026. These financial ratios cover 40 quarters of results from Sep 2016 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -328.64% | -431.16% | -81.42% | -4,551.00% | 180,342.11% | 54.67% | 82.63% | -750.95% | -719.36% | 81.01% | -41.15% | -623.86% | -834.87% | -594.24% | 4.05% | 77.35% | ||||||||||||||||||||||||
| EBIT Margin | -329.83% | -429.57% | -82.07% | -4,604.78% | 192,189.47% | 46.10% | 80.92% | -930.96% | -886.70% | 76.84% | -68.18% | -758.04% | -985.17% | -677.09% | -6.47% | 74.37% | ||||||||||||||||||||||||
| EBITDA Margin | -329.83% | -429.57% | -82.07% | -4,604.78% | 192,189.47% | 46.10% | 80.92% | -930.96% | -886.70% | 76.84% | -68.18% | -758.04% | -985.17% | -677.09% | -6.47% | 74.37% | ||||||||||||||||||||||||
| Operating Margin | -329.83% | -429.57% | -82.07% | -4,604.78% | 192,189.47% | 46.10% | 80.92% | -930.96% | -886.70% | 76.84% | -68.18% | -758.04% | -985.17% | -677.09% | -6.47% | 74.37% | ||||||||||||||||||||||||
| Net Margin | -328.64% | -431.16% | -81.42% | -4,551.00% | 180,342.11% | 87.83% | 81.32% | -734.15% | -710.37% | 46.80% | -41.15% | -627.46% | -834.87% | -226.42% | 6.71% | 76.27% | ||||||||||||||||||||||||
| FCF Margin | -279.36% | -314.90% | -147.50% | -1,547.22% | 166,868.42% | 33.88% | -10.85% | 6,445.62% | -612.47% | -17.87% | 440.73% | -533.59% | -42.98% | -499.11% | -87.21% | 102.32% | ||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 388.70M | 360.44M | 348.00M | 329.40M | 296.34M | 265.05M | 243.89M | 280.16M | 325.24M | 343.98M | 493.61M | 621.95M | 609.24M | 674.29M | 743.43M | 730.07M | 709.85M | 684.94M | 682.82M | 791.50M | ||||||||||||||||||||
| Invested CapitalInvested Cap. | 330.78M | 300.92M | 302.16M | 268.06M | 243.65M | 215.68M | 216.19M | 294.08M | ||||||||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.06 | 0.08 | 0.13 | 0.14 | 0.12 | 0.10 | 0.00 | 0.00 | 0.00 | 0.15 | 0.62 | 0.50 | 0.52 | 0.64 | 0.27 | 0.28 | 0.29 | 0.07 | 0.11 | 0.36 | ||||||||||||||||||||
| Leverage & Solvency | ||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | ||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||||||||||||||
| Times Interest Earned | ||||||||||||||||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -24.99 | -44.04 | -54.90 | -9.40 | -13.32 | -15.71 | -35.08 | -41.29 | -28.19 | 30.13 | 8.18 | -66.56 | -80.65 | 30.51 | -256.96 | -98.64 | -105.45 | -324.58 | 0.00M | 48.69 | ||||||||||||||||||||
| Price to SalesP/S | 82.13 | 189.87 | 44.70 | 427.88 | -0.03M | 26.47 | 6.65 | 488.63 | 572.94 | 14.28 | 105.75 | 618.95 | 880.38 | 734.91 | 120.10 | 37.14 | ||||||||||||||||||||||||
| Price to BookP/B | 2.56 | 5.45 | 3.81 | 1.44 | 1.70 | 2.50 | 5.47 | 5.40 | 3.18 | 3.93 | 3.02 | 3.76 | 5.04 | 3.49 | 4.35 | 5.14 | 6.43 | 8.89 | 10.33 | 9.42 | ||||||||||||||||||||
| Enterprise Value | 530.40M | 1,309.17M | 844.42M | 93.15M | 147.31M | 300.94M | 952.35M | 1,274.59M | 640.81M | 981.63M | 1,372.65M | 1,472.06M | 2,209.76M | 1,937.01M | 2,420.51M | 2,862.22M | 3,572.24M | 4,898.16M | 6,221.72M | 7,144.92M | ||||||||||||||||||||
| EV to EBIT | -15.63 | -35.37 | -40.00 | -2.25 | -4.56 | -8.24 | -26.44 | -30.09 | -16.72 | 42.59 | 6.65 | -37.95 | -53.31 | 15.28 | -125.35 | -68.08 | -76.95 | -97.27 | -0.00M | 45.00 | ||||||||||||||||||||
| EV to EBITDA | -15.63 | -35.37 | -40.00 | -2.25 | -4.56 | -8.24 | -26.44 | -30.09 | -16.72 | 42.59 | 6.65 | -37.95 | -53.31 | 15.28 | -125.35 | -68.08 | -76.95 | -97.27 | -0.00M | 45.00 | ||||||||||||||||||||
| Market Capitalization | 844.74M | 1,636.07M | 1,149.71M | 385.09M | 414.74M | 538.29M | 1,183.13M | 1,587.99M | 961.56M | 1,323.26M | 1,695.32M | 2,036.11M | 2,678.49M | 2,355.96M | 2,994.87M | 3,432.69M | 4,148.36M | 5,465.55M | 6,769.53M | 7,927.50M | ||||||||||||||||||||
| Price to FCFP/FCF | -29.40 | -60.29 | -30.30 | -27.65 | -16.35 | -16.98 | -34.43 | -60.13 | -35.59 | 78.11 | -61.27 | 7.58 | -93.55 | -79.90 | 23.99 | -116.00 | -0.00M | -147.24 | -137.71 | 36.29 | ||||||||||||||||||||
| EV to FCF | -18.46 | -48.25 | -22.26 | -6.69 | -5.81 | -9.49 | -27.72 | -48.26 | -23.72 | 57.94 | -49.61 | 5.48 | -77.18 | -65.69 | 19.39 | -96.72 | -0.00M | -131.96 | -126.57 | 32.71 | ||||||||||||||||||||
| EV to CFO | -18.63 | -48.60 | -22.42 | -6.83 | -5.85 | -9.51 | -27.73 | -48.58 | -24.08 | 57.88 | -50.04 | 5.48 | -79.31 | -66.39 | 19.31 | -99.45 | -0.00M | -132.47 | -127.12 | 32.62 | ||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -329.83% | -429.57% | -82.07% | -4,604.78% | -374.22% | 192,189.47% | -16,604.20% | 774,705.26% | 806,405.26% | 46.10% | 80.92% | -930.96% | -886.70% | 76.84% | -68.18% | -758.04% | -985.17% | -677.09% | -6.47% | 74.37% | ||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -30.80% | -39.77% | -40.37% | -46.14% | -50.80% | -56.17% | -66.29% | -58.00% | -51.52% | -29.02% | 32.77% | 26.23% | 26.41% | 40.33% | 3.84% | 3.45% | 2.86% | -24.73% | -21.98% | 7.73% | ||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | ||||||||||||||||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -29.27% | -34.90% | -35.27% | -40.33% | -43.94% | -48.03% | -57.44% | -49.11% | -43.22% | -18.13% | 36.20% | 30.00% | 30.77% | 32.74% | 0.24% | -0.34% | -1.21% | -14.98% | -12.77% | 13.95% |